(Q36790607)

16 August 2017

title

Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors (English)

1 reference

16 August 2017

1 reference

Herbert B Newton

1

1 reference

16 August 2017

Jennifer Dalton

series ordinal

2

1 reference

16 August 2017

Samuel Goldlust

series ordinal

3

1 reference

16 August 2017

Dennis Pearl

series ordinal

4

1 reference

16 August 2017

publication date

13 April 2007

1 reference

Journal of Neuro-Oncology

16 August 2017

published in

1 reference

16 August 2017

volume

84

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

293-296

1 reference

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

16 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9373-8

Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9373-8

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9373-8

Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.

21 January 2018

1 reference

12 December 2020

Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium

1 reference

12 December 2020

Management of brain metastases

1 reference

12 December 2020

Levetiracetam: preliminary experience in patients with primary brain tumours

1 reference

12 December 2020

Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

1 reference

12 December 2020

Psychopharmacology of anticonvulsants: levetiracetam as a synaptic vesicle protein modulator.

1 reference

12 December 2020

Clinical experience of levetiracetam monotherapy for adults with epilepsy: 1-year follow-up study.

1 reference

12 December 2020

Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy

1 reference

12 December 2020

Brain tumor and seizures: pathophysiology and its implications for treatment revisited

1 reference

12 December 2020

Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients

1 reference

12 December 2020

Intracranial metastases from systemic cancer

1 reference

12 December 2020

Levetiracetam therapy in patients with brain tumour and epilepsy.

1 reference

12 December 2020

Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes

1 reference

12 December 2020

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

12 December 2020

Diagnosis and management of brain metastases

1 reference

12 December 2020

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

1 reference

12 December 2020

A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults

1 reference

12 December 2020

Selective blockade of N-type calcium channels by levetiracetam

1 reference

12 December 2020

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

12 December 2020

Expression of brain-derived neurotrophic factor (BDNF) and inducible nitric oxide synthase (iNOS) in rat astrocyte cultures treated with Levetiracetam.

1 reference

12 December 2020

Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia

1 reference

12 December 2020

Treating seizures in patients with brain tumors: Drug interactions between antiepileptic and chemotherapeutic agents

1 reference

12 December 2020

[The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna].

1 reference

12 December 2020

10.1007/S11060-007-9373-8

Identifiers

DOI

1 reference

16 August 2017

1 reference